U.S. markets open in 4 hours 12 minutes
  • S&P Futures

    4,230.75
    +21.00 (+0.50%)
     
  • Dow Futures

    33,457.00
    +153.00 (+0.46%)
     
  • Nasdaq Futures

    13,382.00
    +70.75 (+0.53%)
     
  • Russell 2000 Futures

    1,988.80
    +12.50 (+0.63%)
     
  • Crude Oil

    94.12
    -0.22 (-0.23%)
     
  • Gold

    1,801.80
    -5.40 (-0.30%)
     
  • Silver

    20.27
    -0.08 (-0.39%)
     
  • EUR/USD

    1.0300
    -0.0026 (-0.25%)
     
  • 10-Yr Bond

    2.8880
    0.0000 (0.00%)
     
  • Vix

    20.06
    +0.32 (+1.62%)
     
  • GBP/USD

    1.2151
    -0.0052 (-0.42%)
     
  • USD/JPY

    133.2910
    +0.2920 (+0.22%)
     
  • BTC-USD

    23,955.29
    -549.09 (-2.24%)
     
  • CMC Crypto 200

    569.67
    -5.08 (-0.88%)
     
  • FTSE 100

    7,503.87
    +37.96 (+0.51%)
     
  • Nikkei 225

    28,546.98
    +727.65 (+2.62%)
     

Amylyx Pharmaceuticals Stock Clears Key Benchmark, Hitting 90-Plus RS Rating

·1 min read
Amylyx Pharmaceuticals Stock Clears Key Benchmark, Hitting 90-Plus RS Rating
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

Amylyx Pharmaceuticals shows improving price performance, earning an upgrade to its IBD Relative Strength Rating.